Real-time context
Follow the latest analyst actions, insider and institutional activity, earnings, dividends, price moves, and company filings.
Rating Change Bernstein analysts reiterated a Outperform rating on Linde plc (NASDAQ:LIN) on August 03, 2026. Market Context Linde plc operates in the Basic Materials sector. The…
Read moreRating Change Citigroup analysts reiterated a Buy rating on Linde plc (NASDAQ:LIN) on August 03, 2026. Market Context Linde plc operates in the Basic Materials sector. The stock…
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on Linde plc (NASDAQ:LIN) on August 03, 2026. Market Context Linde plc operates in the Basic Materials sector.…
Read moreRating Change Truist Securities analysts downgraded Intuit Inc. (NASDAQ:INTU) from Buy to Hold on August 03, 2026. Market Context Intuit Inc.
Read moreRating Change UBS analysts reiterated a Neutral rating on Citigroup Inc. (NYSE:C) on August 03, 2026. Market Context Citigroup Inc.
Read moreRating Change Bernstein analysts reiterated a Market Perform rating on RTX Corporation (NYSE:RTX) on August 03, 2026. Market Context RTX Corporation operates in the Industrials…
Read moreRating Change UBS analysts reiterated a Neutral rating on American Express Company (NYSE:AXP) on August 03, 2026. Market Context American Express Company operates in the Financial…
Read moreRating Change Barclays analysts reiterated a Equal-Weight rating on Chevron Corporation (NYSE:CVX) on August 03, 2026. Market Context Chevron Corporation operates in the Energy…
Read moreRating Change Bernstein analysts reiterated a Market Perform rating on Chevron Corporation (NYSE:CVX) on August 03, 2026. Market Context Chevron Corporation operates in the Energy…
Read moreRating Change Cantor Fitzgerald analysts reiterated a Overweight rating on Visa Inc. (NYSE:V) on August 03, 2026. Market Context Visa Inc.
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on Ligand Pharmaceuticals, Inc. (OTC:LGNXZ) on August 03, 2026. Market Context Ligand Pharmaceuticals, Inc.
Read moreRating Change Oppenheimer analysts reiterated a Outperform rating on Ligand Pharmaceuticals, Inc. (OTC:LGNZZ) on August 03, 2026. Market Context Ligand Pharmaceuticals, Inc.
Read moreRating Change Macquarie analysts reiterated a Outperform rating on AXS SPAC and New Issue ETF (NASDAQ:SPCX) on August 03, 2026. Market Context AXS SPAC and New Issue ETF operates…
Read moreRating Change RBC Capital analysts reiterated a Outperform rating on AXS SPAC and New Issue ETF (NASDAQ:SPCX) on August 03, 2026. Market Context AXS SPAC and New Issue ETF…
Read moreEarnings Results Organon (NYSE:OGN) reported quarterly earnings results on July 31, 2026 that fell short of analyst expectations. The Healthcare company reported earnings per…
Read moreEarnings Results EverQuote (NASDAQ:EVER) reported quarterly earnings results on August 03, 2026 that fell short of analyst expectations. The Communication Services company…
Read moreEarnings Results Viper Energy (NASDAQ:VNOM) reported quarterly earnings results on August 03, 2026 that fell short of analyst expectations. The Energy company reported earnings…
Read moreEarnings Results Offerpad Solutions (NYSE:OPAD) reported quarterly earnings results on August 03, 2026 that fell short of analyst expectations. The Real Estate company reported…
Read moreEarnings Results Voyager Technologies (NYSE:VOYG) reported quarterly earnings results on August 03, 2026 that exceeded analyst expectations. The Industrials company reported…
Read moreEarnings Results CRISPR Therapeutics (NASDAQ:CRSP) reported quarterly earnings results on August 03, 2026 that exceeded analyst expectations. The Healthcare company reported…
Read more
